Opportunistic Test-And-Treat Approach Superior To Referral-Based Standard Care For Hospitalized Patients With HCV Infection With A History Of Injection Drug Use, Study Finds
January 23, 2024
Infectious Disease Advisor (1/22) reports, “An opportunistic test-and-treat approach is superior to referral-based standard care for individuals hospitalized with hepatitis C virus (HCV) infection with a history of injection drug use, according to findings published in Clinical Infectious Diseases.” In the study, “treatment completion was achieved by 68.4% (95% CI, 58.2-77.4) of patients during intervention conditions and 35.3% (95% CI, 26.1-45.4) during control conditions (risk ratio, 1.9; 95% CI, 1.4-2.6).”